HealthTree Foundation

Blood Cancer Patient Empowerment - healthtree.org
The HealthTree Foundation empowers patients with blood cancers at each step of their disease journey – from diagnosis, through education, care and on to a cure. The HealthTree Foundation does this through three areas of support; simplified patient education, support research driven by patient needs, and the use of data to solve patient and research problems.

Donate to the HealthTree Foundation or learn more about additional myeloma support we offer here: https://give.healthtree.org/campaign/healthtree-foundation-10-year-celebration/c440295

Сильная позиция: история сиделки о том, как она справляется с раком крови у мужа | Месяц сиделки ...

Что такое HealthTree? | Мощный ресурс для пациентов с раком крови и их семей

Волонтеры вносят свой вклад в борьбу с коронавирусом: Сусана Виварес

Вместе мы заботимся. Вместе мы лечим: взгляд изнутри на программы HealthTree для пациентов с рако...

2025 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

Unshaken: The Inspiring Cancer Story of Jason Mook | Documentary Trailer

Connect to Cures Blood Cancer Event - Harrisonburg, VA

Connect to Cures Blood Cancer Event - Orlando, FL

4th Annual Black Health Movement Event

Connect to Cures Blood Cancer Event - Peoria, IL

Connect to Cures Blood Cancer Event - Macon, GA

HealthTree Cure Teams - Volunteers Making an Impact

Преодолевая трудности: моя борьба с детской лейкемией | Алик Топалян

Minimal Residual Disease (MRD) Testing with Dr. Rafael Fonseca

Эрин Хилл | От диагноза к цели

Stronger Together | Paola and Luis' Journey with Multiple Myeloma

Jackie McFarlin | Myeloma Warrior

2025 HealthTree Hike and Wellness Challenge

Preventing Myeloma Progression with Diet: The Nutrivention-2 Stu

Why I Participate in Clinical Trials: Deborah “De” Brown’s Journey with Multiple Myeloma

Будущее лечения рака | HealthTree Cure Hub

#Myeloma Patient Preferences: HealthTree Decision-Making Survey | Manni Mohyuddin, MD | #ASH24

The Future of Bispecific Antibodies with Dr. Philippe Moreau

Dara-RVd lite for High Risk Smoldering Myeloma | Omar Nadeem, MD | #ASH24

Treating High-Risk Smoldering Myeloma using CAR-T - CAR-PRISM Study | Omar Nadeem, MD | #ASH24

The Future of MRD Testing: Why It Matters for Multiple Myeloma Patients and What Comes Next

How a Therapist is Dealing with Blood Cancer | Harriet Cabelly | Stories that Change Us

Building a Myeloma-Specific Score to Predict CAR-T Therapy Toxicities | Utkarsh Goel MD | #ASH24

ASH 2024 Wrap-Up: What's next in #Myeloma Treatment | Claudio Cerchione, MD | #ASH24